Efimosfermin alfa (development code BOS-580) is a long-acting fibroblast growth factor 21 analog that can be injected once monthly. It was acquired by Boston Pharmaceuticals from Novartis in 2020.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.